To check efficacy of Shunthi Bidalak in redness of eyes .

A Randomized Controlled Clinical study of Shunthi Bidalak in Simple Allergic Conjunctivitis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079200

Enrollment

Registered

2025-01-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Participants suffering from Simple Allergic Conjunctivitis. 1 Age 18 to 60 years 2 Gender Both male and female

Exclusion criteria

Exclusion criteria: 1 Participants suffering from ocular surface pathology. 2 post-operative participants. 3 Participants suffering from all other type of conjunctivitis.

Design outcomes

Primary

Measure	Time frame
Reduction of Itching. Reduction of Burning sensation. Reduction of Redness. Reduction of Photophobia. Reduction of Lacrimation.Timepoint: 14 days	—

Secondary

Measure	Time frame
Relief From Signs And SymptomsTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Gajanan Patil

Bharati Vidyapeeth (Deemed To be University ) , College of Ayurveda, Pune-43

patil.gajanan1@bharatividyapeeth.edu9923037117

Outcome results